Clinical Relevance of Steroid Use in Neuro-Oncology

Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given th...

Full description

Saved in:
Bibliographic Details
Published inCurrent Neurology and Neuroscience Reports Vol. 17; no. 1; p. 5
Main Authors Ly, K. Ina, Wen, Patrick Y.
Format Journal Article Book Review
LanguageEnglish
Published New York Springer US 2017
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given their wide range of adverse effects. Purpose of Review To review the mechanism of action, pharmacology, and toxicity profile of corticosteroids and to critically appraise the evidence that supports their use in neuro-oncologic practice based on the latest scientific and clinical data. Recent Findings Recent data suggest that corticosteroids may negatively impact survival in glioma patients. In addition, corticosteroids should be incorporated as a standard criterion to assess a patient’s clinical and radiographic response to treatment. Summary Corticosteroids should be used judiciously in neuro-oncologic patients, given the potential deleterious effects on clinical outcome and patient survival. Anti-angiogenic agents, which lack these adverse effects, may be a reasonable alternative to corticosteroids.
AbstractList Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given their wide range of adverse effects. To review the mechanism of action, pharmacology, and toxicity profile of corticosteroids and to critically appraise the evidence that supports their use in neuro-oncologic practice based on the latest scientific and clinical data. Recent data suggest that corticosteroids may negatively impact survival in glioma patients. In addition, corticosteroids should be incorporated as a standard criterion to assess a patient's clinical and radiographic response to treatment. Corticosteroids should be used judiciously in neuro-oncologic patients, given the potential deleterious effects on clinical outcome and patient survival. Anti-angiogenic agents, which lack these adverse effects, may be a reasonable alternative to corticosteroids.
Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given their wide range of adverse effects. Purpose of Review To review the mechanism of action, pharmacology, and toxicity profile of corticosteroids and to critically appraise the evidence that supports their use in neuro-oncologic practice based on the latest scientific and clinical data. Recent Findings Recent data suggest that corticosteroids may negatively impact survival in glioma patients. In addition, corticosteroids should be incorporated as a standard criterion to assess a patient's clinical and radiographic response to treatment. Summary Corticosteroids should be used judiciously in neuro-oncologic patients, given the potential deleterious effects on clinical outcome and patient survival. Anti-angiogenic agents, which lack these adverse effects, may be a reasonable alternative to corticosteroids.
BACKGROUNDCorticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given their wide range of adverse effects.PURPOSE OF REVIEWTo review the mechanism of action, pharmacology, and toxicity profile of corticosteroids and to critically appraise the evidence that supports their use in neuro-oncologic practice based on the latest scientific and clinical data.RECENT FINDINGSRecent data suggest that corticosteroids may negatively impact survival in glioma patients. In addition, corticosteroids should be incorporated as a standard criterion to assess a patient's clinical and radiographic response to treatment. Corticosteroids should be used judiciously in neuro-oncologic patients, given the potential deleterious effects on clinical outcome and patient survival. Anti-angiogenic agents, which lack these adverse effects, may be a reasonable alternative to corticosteroids.
Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related cerebral edema and improve neurologic function. However, they are also associated with significant morbidity and mortality, given their wide range of adverse effects. Purpose of Review To review the mechanism of action, pharmacology, and toxicity profile of corticosteroids and to critically appraise the evidence that supports their use in neuro-oncologic practice based on the latest scientific and clinical data. Recent Findings Recent data suggest that corticosteroids may negatively impact survival in glioma patients. In addition, corticosteroids should be incorporated as a standard criterion to assess a patient’s clinical and radiographic response to treatment. Summary Corticosteroids should be used judiciously in neuro-oncologic patients, given the potential deleterious effects on clinical outcome and patient survival. Anti-angiogenic agents, which lack these adverse effects, may be a reasonable alternative to corticosteroids.
ArticleNumber 5
Author Ly, K. Ina
Wen, Patrick Y.
Author_xml – sequence: 1
  givenname: K. Ina
  surname: Ly
  fullname: Ly, K. Ina
  organization: Center for Neuro-Oncology, Dana-Farber Cancer Institute, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
– sequence: 2
  givenname: Patrick Y.
  surname: Wen
  fullname: Wen, Patrick Y.
  email: patrick_wen@dfci.harvard.edu
  organization: Center for Neuro-Oncology, Dana-Farber Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28138871$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1LAzEQhoNUtFV_gBdZ8OIlOpNkN9mjFL9AFNSeQ3Y7lZVtoklX6L93l1YRwVMG8rzvDM-EjXzwxNgxwjkC6IuEWCJwQM1Bo-TFDhtjLhUvRClHwywMV6DEPpuk9AYg-lS5x_aFQWmMxjGT07bxTe3a7Ila-nS-piwssucVxdDMs1mirPHZA3Ux8Edfhza8rg_Z7sK1iY627wGbXV-9TG_5_ePN3fTyntdSixWvhHGqUALIoVFYOSdICgEid7KogIiMNMUctDZK67wqJCLouiylWkgHIA_Y2ab3PYaPjtLKLptUU9s6T6FLFk0hRW9ADejpH_QtdNH31w1ULnJT5qKncEPVMaQUaWHfY7N0cW0R7GDUboza3qgdjNqiz5xsm7tqSfOfxLfCHhAbIPVf_pXir9X_tn4BlZF-lQ
CitedBy_id crossref_primary_10_1093_nop_npab039
crossref_primary_10_1016_j_neuchi_2020_12_008
crossref_primary_10_3390_biomedicines11102731
crossref_primary_10_1016_j_wneu_2022_03_118
crossref_primary_10_1155_2019_3267409
crossref_primary_10_1186_s12885_019_5678_1
crossref_primary_10_1007_s11910_019_1010_3
crossref_primary_10_1182_bloodadvances_2020001977
crossref_primary_10_1007_s00520_020_05635_2
crossref_primary_10_3389_fonc_2023_1335730
crossref_primary_10_1093_nop_npy011
crossref_primary_10_3390_cancers10120492
crossref_primary_10_3390_cancers13225735
crossref_primary_10_1007_s11060_018_03007_9
crossref_primary_10_1093_neuonc_noac118
crossref_primary_10_1212_CON_0000000000000940
crossref_primary_10_1212_CON_0000000000001359
crossref_primary_10_3389_fimmu_2024_1326757
crossref_primary_10_1016_j_psiq_2019_02_007
crossref_primary_10_1021_acs_jmedchem_2c01824
crossref_primary_10_1080_15384047_2018_1433499
crossref_primary_10_4103_0028_3886_359216
crossref_primary_10_1007_s11060_019_03238_4
crossref_primary_10_1016_j_wneu_2021_12_067
crossref_primary_10_3389_fonc_2021_617966
crossref_primary_10_1007_s11060_023_04549_3
crossref_primary_10_1093_noajnl_vdaa038
crossref_primary_10_3390_ijms22041791
crossref_primary_10_1093_nop_npac013
crossref_primary_10_1007_s00381_021_05354_x
crossref_primary_10_1093_neuonc_noaa106
Cites_doi 10.1007/s11060-010-0142-8
10.7326/0003-4819-90-2-207
10.3171/jns.1995.83.4.0682
10.1371/journal.pone.0078699
10.1016/j.mri.2006.09.002
10.1212/WNL.35.11.1610
10.1113/jphysiol.2006.106385
10.1186/s13014-015-0527-0
10.1227/01.NEU.0000204873.68395.A0
10.1038/sj.onc.1204498
10.1073/pnas.0800165105
10.3109/02841868909111181
10.1371/journal.pcbi.1003295
10.1056/NEJM198307073090105
10.1007/s00198-007-0394-0
10.1176/appi.ajp.2011.11071009
10.1586/ecp.11.1
10.1186/1471-2407-13-402
10.1136/bmjopen-2013-004259
10.1111/j.1365-2133.2007.07950.x
10.1200/JCO.2009.26.3541
10.1093/neuonc/nov054
10.1001/archneur.1991.00530160074017
10.7326/0003-4819-81-4-505
10.1016/j.steroids.2005.02.006
10.1016/S0090-3019(81)80054-7
10.1136/ard.2003.010355
10.1097/00006123-199705000-00027
10.1016/0002-9343(94)90131-7
10.1212/01.wnl.0000208958.29600.87
10.1086/339548
10.1038/nature10144
10.1007/s00520-007-0395-8
10.3171/foc.2007.22.5.13
10.1016/0165-6147(91)90531-V
10.1016/j.ccr.2006.11.021
10.1200/JCO.1994.12.9.1886
10.1093/brain/aww046
10.1210/jcem-60-5-848
10.1007/s11060-009-0057-4
10.1007/s001980200108
10.1007/s00520-001-0333-0
10.1111/j.1349-7006.1999.tb00795.x
10.1111/j.1749-6632.2002.tb04204.x
10.3171/jns.1981.55.5.0757
10.1210/endo.141.8.7621
10.1016/j.ejphar.2007.12.033
10.1227/01.neu.0000318183.25783.77
10.1007/s11864-016-0413-5
10.4088/PCC.v03n0104
10.1136/jnnp.47.10.1087
10.3747/co.21.1769
10.1215/15228517-4-1-22
10.1016/S0889-8529(05)70348-0
10.1002/glia.20168
10.1634/theoncologist.2010-0105
10.1212/WNL.44.4.675
10.1056/NEJM195204102461502
10.1212/WNL.41.8.1235
10.2165/00003088-200544010-00003
10.1007/BF00165531
10.1359/jbmr.2000.15.6.993
10.4158/EP08331.RAR
10.3109/02841869309093600
10.1080/07357900701206380
10.1007/BF01402116
10.1002/art.21984
10.1093/rheumatology/kes353
10.1227/NEU.0b013e3181fa775b
10.1200/JCO.2012.43.9455
10.1200/JCO.1990.8.7.1277
10.1089/jpm.2014.9417
10.1001/jama.1957.02970510039008
10.1056/NEJM196907032810108
10.1007/978-94-011-0826-3_16
10.1177/106002809002400301
10.1002/14651858.CD005590.pub3
ContentType Journal Article
Book Review
Copyright Springer Science+Business Media New York 2017
Current Neurology and Neuroscience Reports is a copyright of Springer, 2017.
Copyright_xml – notice: Springer Science+Business Media New York 2017
– notice: Current Neurology and Neuroscience Reports is a copyright of Springer, 2017.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
88G
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1007/s11910-017-0713-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest One Psychology
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-6293
EndPage 5
ExternalDocumentID 4312395391
10_1007_s11910_017_0713_6
28138871
Genre Journal Article
Review
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29F
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40D
40E
53G
5GY
5VS
6NX
7X7
875
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACREN
ACSNA
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
AZQEC
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C1A
CAG
CCPQU
COF
CS3
CSCUP
CUW
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
HF~
HG6
HMCUK
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
I~Z
J-C
JBSCW
JZLTJ
KOV
LLZTM
M1P
M2M
M4Y
MA-
N9A
NPVJJ
NQJWS
NU0
O9-
O9J
OVD
P9S
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
Q2X
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WH7
WK8
YLTOR
Z7U
Z7W
Z82
Z87
ZMTXR
ZOVNA
~A9
AACDK
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
SJYHP
AAYXX
CITATION
7TK
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c372t-b28a46420ea1841baa2e322025a36b0eee8386d07784775b631107c9934f3a003
IEDL.DBID BENPR
ISSN 1528-4042
IngestDate Fri Oct 25 01:29:39 EDT 2024
Thu Oct 10 17:28:50 EDT 2024
Thu Sep 12 17:03:10 EDT 2024
Wed Oct 16 00:57:41 EDT 2024
Sat Dec 16 11:59:45 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Brain tumor
Brain metastases
Corticosteroids
Cerebral edema
Response assessment
Steroids
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-b28a46420ea1841baa2e322025a36b0eee8386d07784775b631107c9934f3a003
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 28138871
PQID 1865258952
PQPubID 326346
PageCount 1
ParticipantIDs proquest_miscellaneous_1863219140
proquest_journals_1865258952
crossref_primary_10_1007_s11910_017_0713_6
pubmed_primary_28138871
springer_journals_10_1007_s11910_017_0713_6
PublicationCentury 2000
PublicationDate 1-2017
2017-01-00
2017-1-00
20170101
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 1-2017
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Philadelphia
PublicationTitle Current Neurology and Neuroscience Reports
PublicationTitleAbbrev Curr Neurol Neurosci Rep
PublicationTitleAlternate Curr Neurol Neurosci Rep
PublicationYear 2017
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Saag, Koehnke, Caldwell, Brasington, Burmeister, Zimmerman (CR32) 1994; 96
Michaelsen, Christensen, Grunnet, Stockhausen, Broholm, Kosteljanetz (CR61) 2013; 13
Watling, Lee, Macdonald, Cairncross (CR79) 1994; 12
Dropcho, Soong (CR41) 1991; 41
Recht, Mechtler, Wong, O’Connor, Rodda (CR77) 2013; 31
Malcher-Lopes, Franco, Tasker (CR12) 2008; 583
Kempf, Hatzikirou, Bleicher, Meyer-Hermann (CR66) 2013; 9
Werk, Choi, Sholiton, Olinger, Haque (CR18) 1969; 281
Whittle, Piper, Miller (CR11) 1991; 113
Marantidou, Levy, Duquesne, Ursu, Bailon, Coman (CR33) 2010; 100
Avina-Zubieta, Abrahamowicz, De Vera, Choi, Sayre, Rahman (CR47) 2013; 52
Armitage, Schwindack, Bastin, Whittle (CR80) 2007; 25
Ohnishi, Iwasaki, Hayakawa, Shapiro (CR10) 1990; 51
Shields, Shelton, Shearer, Chen, Sun, Parsons (CR64) 2015; 10
Pitter, Tamagno, Alikhanyan, Hosni-Ahmed, Pattwell, Donnola (CR65) 2016; 139
Weissman, Janjan, Erickson, Wilson, Greenberg, Ritch (CR27) 1991; 11
Armstrong, Ying, Wu, Acquaye, Vera-Bolanos, Gilbert (CR35) 2015; 17
Canalis, Delany (CR42) 2002; 966
Chalk, Ridgeway, Brophy, Yelland, Eadie (CR19) 1984; 47
Eisele, Wen, Lee (CR83) 2016; 17
Sepkowitz (CR56) 2002; 34
Dietrich, Rao, Pastorino, Kesari (CR23) 2011; 4
Messer, Reitman, Sacks, Smith, Chalmers (CR49) 1983; 309
Kotsarini, Griffiths, Wilkinson, Hoggard (CR6) 2010; 67
Sun, Trausch-Azar, Muglia, Schwartz (CR39) 2008; 105
Yano, Shinohara, Herbst, Kuniyasu, Bucana, Ellis (CR73) 2000; 60
Galicich, French, Melby (CR3) 1961; 81
Lo, Gore, Bradley, Buatti, Germano (CR30) 2014; 17
Pope, Lai, Nghiemphu, Mischel, Cloughesy (CR75) 2006; 66
Vecht, Hovestadt, Verbiest, van Vliet, van Putten (CR28) 1994; 44
Henson, Jalaj, Walker, Stover, Fels (CR57) 1991; 48
Melby (CR26) 1974; 81
Forster, Waschke, Burek, Leers, Drenckhahn (CR7) 2006; 573
Watne, Hannisdal, Nome, Hager, Hirschberg (CR63) 1993; 32
Raslan, Bhardwaj (CR25) 2007; 22
Walsh, Doona, Molnar, Lipnickey (CR4) 2000; 27
Curtis, Westfall, Allison, Bijlsma, Freeman, George (CR36) 2006; 55
Sur, Sribnick, Patel, Ray, Banik (CR70) 2005; 50
Singleton, Baker, Thorburn (CR40) 2000; 141
Brown, Chandler (CR38) 2001; 3
Ajeganova, Svensson, Hafstrom, Group (CR46) 2014; 4
Ingraham, Matson, Mc (CR1) 1952; 246
Hohwieler Schloss, Freidberg, Heatley, Lo (CR62) 1989; 28
Penry, Newmark (CR21) 1979; 90
Stern, Green, Paul, Vidal, Leibovici (CR60) 2014; 10
CR59
Kofman, Garvin, Nagamani, Taylor (CR2) 1957; 163
Yu, Wrange, Boethius, Hatam, Granholm, Gustafsson (CR9) 1981; 55
McEwen (CR16) 1991; 12
Clore, Thurby-Hay (CR51) 2009; 15
Macdonald, Cascino, Schold, Cairncross (CR81) 1990; 8
Kokunai, Tamaki (CR69) 1999; 90
McClelland, Long (CR24) 2008; 62
Schwarzberg, Stover, Sengupta, Michelini, Vincitore, Baden (CR58) 2007; 25
Hempen, Weiss, Hess (CR34) 2002; 10
Czock, Keller, Rasche, Haussler (CR5) 2005; 44
Ryken, McDermott, Robinson, Ammirati, Andrews, Asher (CR29) 2010; 96
Zhou, Cidlowski (CR15) 2005; 70
Whitworth (CR48) 1992; 37
Mpofu, Mpofu, Hutchinson, Maier, Dodd, Moots (CR50) 2004; 63
Van Staa, Leufkens, Abenhaim, Zhang, Cooper (CR45) 2000; 15
Sturdza, Millar, Bana, Laperriere, Pond, Wong (CR53) 2008; 16
Provias, Claffey, del Aguila, Lau, Feldkamp, Guha (CR71) 1997; 40
Vredenburgh, Cloughesy, Samant, Prados, Wen, Mikkelsen (CR76) 2010; 15
Canalis, Mazziotti, Giustina, Bilezikian (CR43) 2007; 18
Allen (CR52) 1996; 25
Fardet, Flahault, Kettaneh, Tiev, Genereau, Toledano (CR55) 2007; 157
Wen, Macdonald, Reardon, Cloughesy, Sorensen, Galanis (CR82) 2010; 28
Lawson, Blouin, Smith, Rapp, Young (CR20) 1981; 16
Wilkinson, Jellineck, Levy, Giesel, Romanowski, Miller (CR14) 2006; 58
Kawai, Ichikawa, Homma (CR22) 1985; 60
Leenders, Beaney, Brooks, Lammertsma, Heather, McKenzie (CR13) 1985; 35
CR67
Batchelor, Sorensen, di Tomaso, Zhang, Duda, Cohen (CR74) 2007; 11
Strugar, Criscuolo, Rothbart, Harrington (CR72) 1995; 83
Migita, Arai, Ishizuka, Jiuchi, Sasaki, Izumi (CR54) 2013; 8
Portnow, Suleman, Grossman, Eller, Carson (CR78) 2002; 4
Cummings, Larijani, Conner, Ferguson, Rocci (CR17) 1990; 24
Carmeliet, Jain (CR8) 2011; 473
Fardet, Petersen, Nazareth (CR37) 2012; 169
Glaser, Wagenknecht, Weller (CR68) 2001; 20
van Staa, Leufkens, Cooper (CR44) 2002; 13
Kostaras, Cusano, Kline, Roa, Easaw (CR31) 2014; 21
21107211 - Neurosurgery. 2010 Dec;67(6):1799-815; discussion 1815
24004722 - BMC Cancer. 2013 Sep 03;13:402
10919283 - Endocrinology. 2000 Aug;141(8):2945-50
8879994 - Endocrinol Metab Clin North Am. 1996 Sep;25(3):699-717
23192907 - Rheumatology (Oxford). 2013 Jan;52(1):68-75
19454391 - Endocr Pract. 2009 Jul-Aug;15(5):469-74
18296633 - Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3339-44
5814988 - N Engl J Med. 1969 Jul 3;281(1):32-4
15634032 - Clin Pharmacokinet. 2005;44(1):61-98
17612935 - Cancer Invest. 2007 Jun;25(4):249-55
16575327 - Neurosurgery. 2006 Apr;58(4):640-6; discussion 640-6
18295199 - Eur J Pharmacol. 2008 Apr 7;583(2-3):322-39
1866012 - Neurology. 1991 Aug;41(8):1235-9
2316228 - DICP. 1990 Mar;24(3):229-31
4137614 - Ann Intern Med. 1974 Oct;81(4):505-12
6502166 - J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1087-90
2539846 - Acta Oncol. 1989;28(1):51-5
22764363 - Am J Psychiatry. 2012 May;169(5):491-7
8109596 - Am J Med. 1994 Feb;96(2):115-23
12378366 - Osteoporos Int. 2002 Oct;13(10):777-87
27020328 - Brain. 2016 May;139(Pt 5):1458-71
4058751 - Neurology. 1985 Nov;35(11):1610-6
16543270 - J Physiol. 2006 Jun 1;573(Pt 2):413-25
13703072 - J Lancet. 1961 Feb;81:46-53
12114261 - Ann N Y Acad Sci. 2002 Jun;966:73-81
10697023 - Semin Oncol. 2000 Feb;27(1):69-83
11914999 - Clin Infect Dis. 2002 Apr 15;34(8):1098-107
20231676 - J Clin Oncol. 2010 Apr 10;28(11):1963-72
3980669 - J Clin Endocrinol Metab. 1985 May;60(5):848-54
2128584 - Acta Neurochir Suppl (Wien). 1990;51:65-7
8323768 - Acta Oncol. 1993;32(3):307-10
24710131 - BMJ Open. 2014 Apr 07;4(4):e004259
1665951 - Acta Neurochir (Wien). 1991;113(1-2):57-68
23382470 - J Clin Oncol. 2013 Mar 20;31(9):1182-7
12029432 - Support Care Cancer. 2002 May;10(4):322-8
2358840 - J Clin Oncol. 1990 Jul;8(7):1277-80
10429656 - Jpn J Cancer Res. 1999 Jun;90(6):638-46
21666852 - Expert Rev Clin Pharmacol. 2011 Mar;4(2):233-42
11521188 - Oncogene. 2001 Aug 9;20(35):4757-67
26520780 - Radiat Oncol. 2015 Oct 31;10 :222
17222792 - Cancer Cell. 2007 Jan;11(1):83-95
27262709 - Curr Treat Options Oncol. 2016 Jul;17 (7):35
15685605 - Glia. 2005 Apr 15;50(2):160-7
10987313 - Cancer Res. 2000 Sep 1;60(17):4959-67
15862824 - Steroids. 2005 May-Jun;70(5-7):407-17
8083712 - J Clin Oncol. 1994 Sep;12(9):1886-9
17566815 - Osteoporos Int. 2007 Oct;18(10):1319-28
7280966 - Surg Neurol. 1981 Jul;16(1):23-4
18496203 - Neurosurgery. 2008 Apr;62(4):965-7; discussion 967-8
375789 - Ann Intern Med. 1979 Feb;90(2):207-18
2012515 - Arch Neurol. 1991 Apr;48(4):406-9
17371718 - Magn Reson Imaging. 2007 Apr;25(3):303-10
7310497 - J Neurosurg. 1981 Nov;55(5):757-60
24940109 - Curr Oncol. 2014 Jun;21(3):e493-503
16636248 - Neurology. 2006 Apr 25;66(8):1258-60
7674019 - J Neurosurg. 1995 Oct;83(4):682-9
11772429 - Neuro Oncol. 2002 Jan;4(1):22-5
15082493 - Ann Rheum Dis. 2004 May;63(5):588-90
21147867 - Oncologist. 2010;15(12):1329-34
17501951 - Br J Dermatol. 2007 Jul;157(1):142-8
17613230 - Neurosurg Focus. 2007 May 15;22(5):E12
16739208 - Arthritis Rheum. 2006 Jun 15;55(3):420-6
6343871 - N Engl J Med. 1983 Jul 7;309(1):21-4
9149260 - Neurosurgery. 1997 May;40(5):1016-26
13415910 - J Am Med Assoc. 1957 Apr 20;163(16):1473-6
24971478 - J Palliat Med. 2014 Aug;17(8):880-6
15014624 - Prim Care Companion J Clin Psychiatry. 2001 Feb;3(1):17-21
14910860 - N Engl J Med. 1952 Apr 10;246(15):568-71
25269391 - Cochrane Database Syst Rev. 2014 Oct 01;(10):CD005590
21593862 - Nature. 2011 May 19;473(7347):298-307
1321309 - Kidney Int Suppl. 1992 Jun;37:S34-7
24260127 - PLoS One. 2013 Nov 19;8(11):e78699
10841167 - J Bone Miner Res. 2000 Jun;15(6):993-1000
20186461 - J Neurooncol. 2010 Oct;100(1):89-94
19957014 - J Neurooncol. 2010 Jan;96(1):103-14
24244120 - PLoS Comput Biol. 2013;9(11):e1003295
25862766 - Neuro Oncol. 2015 Aug;17(8):1114-20
2063480 - Trends Pharmacol Sci. 1991 Apr;12(4):141-7
18256860 - Support Care Cancer. 2008 Sep;16(9):1041-8
8164824 - Neurology. 1994 Apr;44(4):675-80
1726656 - J Neurooncol. 1991 Dec;11(3):235-9
JN Clore (713_CR51) 2009; 15
LB Shields (713_CR64) 2015; 10
J Provias (713_CR71) 1997; 40
713_CR67
M Hohwieler Schloss (713_CR62) 1989; 28
DE Weissman (713_CR27) 1991; 11
EE Werk Jr (713_CR18) 1969; 281
TP Staa van (713_CR44) 2002; 13
T Ohnishi (713_CR10) 1990; 51
A Sturdza (713_CR53) 2008; 16
LA Lawson (713_CR20) 1981; 16
KG Saag (713_CR32) 1994; 96
P Sur (713_CR70) 2005; 50
JJ Vredenburgh (713_CR76) 2010; 15
ES Brown (713_CR38) 2001; 3
T Glaser (713_CR68) 2001; 20
TC Ryken (713_CR29) 2010; 96
L Recht (713_CR77) 2013; 31
JC Melby (713_CR26) 1974; 81
D Czock (713_CR5) 2005; 44
R Malcher-Lopes (713_CR12) 2008; 583
ZY Yu (713_CR9) 1981; 55
JG Strugar (713_CR72) 1995; 83
BS McEwen (713_CR16) 1991; 12
JA Whitworth (713_CR48) 1992; 37
E Canalis (713_CR42) 2002; 966
S Mpofu (713_CR50) 2004; 63
CJ Watling (713_CR79) 1994; 12
C Forster (713_CR7) 2006; 573
A Raslan (713_CR25) 2007; 22
PA Armitage (713_CR80) 2007; 25
L Fardet (713_CR37) 2012; 169
C Hempen (713_CR34) 2002; 10
JH Galicich (713_CR3) 1961; 81
IR Whittle (713_CR11) 1991; 113
DB Allen (713_CR52) 1996; 25
L Sun (713_CR39) 2008; 105
L Fardet (713_CR55) 2007; 157
J Portnow (713_CR78) 2002; 4
A Stern (713_CR60) 2014; 10
P Carmeliet (713_CR8) 2011; 473
KL Pitter (713_CR65) 2016; 139
K Migita (713_CR54) 2013; 8
WB Pope (713_CR75) 2006; 66
DM Cummings (713_CR17) 1990; 24
CJ Vecht (713_CR28) 1994; 44
S Kawai (713_CR22) 1985; 60
S Yano (713_CR73) 2000; 60
TT Batchelor (713_CR74) 2007; 11
T Kokunai (713_CR69) 1999; 90
K Watne (713_CR63) 1993; 32
J Dietrich (713_CR23) 2011; 4
JK Penry (713_CR21) 1979; 90
ID Wilkinson (713_CR14) 2006; 58
TS Armstrong (713_CR35) 2015; 17
FD Ingraham (713_CR1) 1952; 246
A Marantidou (713_CR33) 2010; 100
KA Sepkowitz (713_CR56) 2002; 34
JA Avina-Zubieta (713_CR47) 2013; 52
EJ Dropcho (713_CR41) 1991; 41
J Zhou (713_CR15) 2005; 70
J Messer (713_CR49) 1983; 309
JB Chalk (713_CR19) 1984; 47
C Kotsarini (713_CR6) 2010; 67
E Canalis (713_CR43) 2007; 18
SS Lo (713_CR30) 2014; 17
713_CR59
JW Henson (713_CR57) 1991; 48
S Ajeganova (713_CR46) 2014; 4
S McClelland 3rd (713_CR24) 2008; 62
SC Eisele (713_CR83) 2016; 17
H Kempf (713_CR66) 2013; 9
JR Curtis (713_CR36) 2006; 55
SR Michaelsen (713_CR61) 2013; 13
PY Wen (713_CR82) 2010; 28
S Kofman (713_CR2) 1957; 163
DR Macdonald (713_CR81) 1990; 8
KL Leenders (713_CR13) 1985; 35
AB Schwarzberg (713_CR58) 2007; 25
TP Staa Van (713_CR45) 2000; 15
D Walsh (713_CR4) 2000; 27
JR Singleton (713_CR40) 2000; 141
X Kostaras (713_CR31) 2014; 21
References_xml – volume: 10
  year: 2014
  ident: CR60
  article-title: Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
  publication-title: Cochrane Database System Rev
  contributor:
    fullname: Leibovici
– volume: 100
  start-page: 89
  issue: 1
  year: 2010
  end-page: 94
  ident: CR33
  article-title: Steroid requirements during radiotherapy for malignant gliomas
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-010-0142-8
  contributor:
    fullname: Coman
– volume: 90
  start-page: 207
  issue: 2
  year: 1979
  end-page: 18
  ident: CR21
  article-title: The use of antiepileptic drugs
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-90-2-207
  contributor:
    fullname: Newmark
– volume: 83
  start-page: 682
  issue: 4
  year: 1995
  end-page: 9
  ident: CR72
  article-title: Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts
  publication-title: J Neurosurg
  doi: 10.3171/jns.1995.83.4.0682
  contributor:
    fullname: Harrington
– volume: 8
  issue: 11
  year: 2013
  ident: CR54
  article-title: Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0078699
  contributor:
    fullname: Izumi
– volume: 25
  start-page: 303
  issue: 3
  year: 2007
  end-page: 10
  ident: CR80
  article-title: Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2006.09.002
  contributor:
    fullname: Whittle
– volume: 35
  start-page: 1610
  issue: 11
  year: 1985
  end-page: 6
  ident: CR13
  article-title: Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization
  publication-title: Neurology
  doi: 10.1212/WNL.35.11.1610
  contributor:
    fullname: McKenzie
– volume: 573
  start-page: 413
  issue: Pt 2
  year: 2006
  end-page: 25
  ident: CR7
  article-title: Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2006.106385
  contributor:
    fullname: Drenckhahn
– volume: 10
  start-page: 222
  year: 2015
  ident: CR64
  article-title: Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-015-0527-0
  contributor:
    fullname: Parsons
– volume: 58
  start-page: 640
  issue: 4
  year: 2006
  end-page: 6
  ident: CR14
  article-title: Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging
  publication-title: Neurosurgery
  doi: 10.1227/01.NEU.0000204873.68395.A0
  contributor:
    fullname: Miller
– volume: 20
  start-page: 4757
  issue: 35
  year: 2001
  end-page: 67
  ident: CR68
  article-title: Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204498
  contributor:
    fullname: Weller
– volume: 105
  start-page: 3339
  issue: 9
  year: 2008
  end-page: 44
  ident: CR39
  article-title: Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0800165105
  contributor:
    fullname: Schwartz
– volume: 28
  start-page: 51
  issue: 1
  year: 1989
  end-page: 5
  ident: CR62
  article-title: Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas
  publication-title: Acta Oncol
  doi: 10.3109/02841868909111181
  contributor:
    fullname: Lo
– volume: 9
  issue: 11
  year: 2013
  ident: CR66
  article-title: In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1003295
  contributor:
    fullname: Meyer-Hermann
– volume: 309
  start-page: 21
  issue: 1
  year: 1983
  end-page: 4
  ident: CR49
  article-title: Association of adrenocorticosteroid therapy and peptic-ulcer disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198307073090105
  contributor:
    fullname: Chalmers
– volume: 18
  start-page: 1319
  issue: 10
  year: 2007
  end-page: 28
  ident: CR43
  article-title: Glucocorticoid-induced osteoporosis: pathophysiology and therapy
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0394-0
  contributor:
    fullname: Bilezikian
– volume: 169
  start-page: 491
  issue: 5
  year: 2012
  end-page: 7
  ident: CR37
  article-title: Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11071009
  contributor:
    fullname: Nazareth
– volume: 24
  start-page: 229
  issue: 3
  year: 1990
  end-page: 31
  ident: CR17
  article-title: Characterization of dexamethasone binding in normal and uremic human serum
  publication-title: DICP
  contributor:
    fullname: Rocci
– volume: 4
  start-page: 233
  issue: 2
  year: 2011
  end-page: 42
  ident: CR23
  article-title: Corticosteroids in brain cancer patients: benefits and pitfalls
  publication-title: Expert Rev Clin Pharmacol
  doi: 10.1586/ecp.11.1
  contributor:
    fullname: Kesari
– volume: 13
  start-page: 402
  year: 2013
  ident: CR61
  article-title: Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-402
  contributor:
    fullname: Kosteljanetz
– volume: 4
  issue: 4
  year: 2014
  ident: CR46
  article-title: Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-004259
  contributor:
    fullname: Group
– volume: 157
  start-page: 142
  issue: 1
  year: 2007
  end-page: 8
  ident: CR55
  article-title: Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2007.07950.x
  contributor:
    fullname: Toledano
– volume: 28
  start-page: 1963
  issue: 11
  year: 2010
  end-page: 72
  ident: CR82
  article-title: Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.2009.26.3541
  contributor:
    fullname: Galanis
– volume: 17
  start-page: 1114
  issue: 8
  year: 2015
  end-page: 20
  ident: CR35
  article-title: The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic
  publication-title: Neuro-Oncology
  doi: 10.1093/neuonc/nov054
  contributor:
    fullname: Gilbert
– volume: 48
  start-page: 406
  issue: 4
  year: 1991
  end-page: 9
  ident: CR57
  article-title: Pneumocystis carinii pneumonia in patients with primary brain tumors
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1991.00530160074017
  contributor:
    fullname: Fels
– volume: 81
  start-page: 505
  issue: 4
  year: 1974
  end-page: 12
  ident: CR26
  article-title: Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-81-4-505
  contributor:
    fullname: Melby
– volume: 51
  start-page: 65
  year: 1990
  end-page: 7
  ident: CR10
  article-title: Possible mechanism of vasogenic brain oedema induced by arachidonic acid
  publication-title: Acta Neurochir Suppl (Wien)
  contributor:
    fullname: Shapiro
– volume: 70
  start-page: 407
  issue: 5–7
  year: 2005
  end-page: 17
  ident: CR15
  article-title: The human glucocorticoid receptor: one gene, multiple proteins and diverse responses
  publication-title: Steroids
  doi: 10.1016/j.steroids.2005.02.006
  contributor:
    fullname: Cidlowski
– volume: 16
  start-page: 23
  issue: 1
  year: 1981
  end-page: 4
  ident: CR20
  article-title: Phenytoin-dexamethasone interaction: a previously unreported observation
  publication-title: Surg Neurol
  doi: 10.1016/S0090-3019(81)80054-7
  contributor:
    fullname: Young
– volume: 63
  start-page: 588
  issue: 5
  year: 2004
  end-page: 90
  ident: CR50
  article-title: Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.010355
  contributor:
    fullname: Moots
– ident: CR67
– volume: 40
  start-page: 1016
  issue: 5
  year: 1997
  end-page: 26
  ident: CR71
  article-title: Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema
  publication-title: Neurosurgery
  doi: 10.1097/00006123-199705000-00027
  contributor:
    fullname: Guha
– volume: 96
  start-page: 115
  issue: 2
  year: 1994
  end-page: 23
  ident: CR32
  article-title: Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events
  publication-title: Am J Med
  doi: 10.1016/0002-9343(94)90131-7
  contributor:
    fullname: Zimmerman
– volume: 66
  start-page: 1258
  issue: 8
  year: 2006
  end-page: 60
  ident: CR75
  article-title: MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000208958.29600.87
  contributor:
    fullname: Cloughesy
– volume: 34
  start-page: 1098
  issue: 8
  year: 2002
  end-page: 107
  ident: CR56
  article-title: Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome
  publication-title: Clin Infect Dis : Off Publ Infect Dis Soc Am
  doi: 10.1086/339548
  contributor:
    fullname: Sepkowitz
– volume: 473
  start-page: 298
  issue: 7347
  year: 2011
  end-page: 307
  ident: CR8
  article-title: Molecular mechanisms and clinical applications of angiogenesis
  publication-title: Nature
  doi: 10.1038/nature10144
  contributor:
    fullname: Jain
– volume: 16
  start-page: 1041
  issue: 9
  year: 2008
  end-page: 8
  ident: CR53
  article-title: The use and toxicity of steroids in the management of patients with brain metastases
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-007-0395-8
  contributor:
    fullname: Wong
– volume: 22
  issue: 5
  year: 2007
  ident: CR25
  article-title: Medical management of cerebral edema
  publication-title: Neurosurg Focus
  doi: 10.3171/foc.2007.22.5.13
  contributor:
    fullname: Bhardwaj
– volume: 12
  start-page: 141
  issue: 4
  year: 1991
  end-page: 7
  ident: CR16
  article-title: Non-genomic and genomic effects of steroids on neural activity
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/0165-6147(91)90531-V
  contributor:
    fullname: McEwen
– volume: 11
  start-page: 83
  issue: 1
  year: 2007
  end-page: 95
  ident: CR74
  article-title: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.11.021
  contributor:
    fullname: Cohen
– volume: 12
  start-page: 1886
  issue: 9
  year: 1994
  end-page: 9
  ident: CR79
  article-title: Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.1994.12.9.1886
  contributor:
    fullname: Cairncross
– volume: 139
  start-page: 1458
  issue: Pt 5
  year: 2016
  end-page: 71
  ident: CR65
  article-title: Corticosteroids compromise survival in glioblastoma
  publication-title: Brain :J Neurol
  doi: 10.1093/brain/aww046
  contributor:
    fullname: Donnola
– volume: 60
  start-page: 848
  issue: 5
  year: 1985
  end-page: 54
  ident: CR22
  article-title: Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-60-5-848
  contributor:
    fullname: Homma
– volume: 96
  start-page: 103
  issue: 1
  year: 2010
  end-page: 14
  ident: CR29
  article-title: The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-009-0057-4
  contributor:
    fullname: Asher
– volume: 13
  start-page: 777
  issue: 10
  year: 2002
  end-page: 87
  ident: CR44
  article-title: The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
  publication-title: Osteoporos Int
  doi: 10.1007/s001980200108
  contributor:
    fullname: Cooper
– volume: 10
  start-page: 322
  issue: 4
  year: 2002
  end-page: 8
  ident: CR34
  article-title: Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-001-0333-0
  contributor:
    fullname: Hess
– volume: 90
  start-page: 638
  issue: 6
  year: 1999
  end-page: 46
  ident: CR69
  article-title: Relationship between expression of p21WAF1/CIP1 and radioresistance in human gliomas
  publication-title: Jpn J Cancer Res
  doi: 10.1111/j.1349-7006.1999.tb00795.x
  contributor:
    fullname: Tamaki
– volume: 966
  start-page: 73
  year: 2002
  end-page: 81
  ident: CR42
  article-title: Mechanisms of glucocorticoid action in bone
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2002.tb04204.x
  contributor:
    fullname: Delany
– volume: 55
  start-page: 757
  issue: 5
  year: 1981
  end-page: 60
  ident: CR9
  article-title: A study of glucocorticoid receptors in intracranial tumors
  publication-title: J Neurosurg
  doi: 10.3171/jns.1981.55.5.0757
  contributor:
    fullname: Gustafsson
– volume: 141
  start-page: 2945
  issue: 8
  year: 2000
  end-page: 50
  ident: CR40
  article-title: Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis
  publication-title: Endocrinology
  doi: 10.1210/endo.141.8.7621
  contributor:
    fullname: Thorburn
– volume: 583
  start-page: 322
  issue: 2–3
  year: 2008
  end-page: 39
  ident: CR12
  article-title: Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2007.12.033
  contributor:
    fullname: Tasker
– volume: 62
  start-page: 965
  issue: 4
  year: 2008
  end-page: 7
  ident: CR24
  article-title: Genesis of the use of corticosteroids in the treatment and prevention of brain edema
  publication-title: Neurosurgery
  doi: 10.1227/01.neu.0000318183.25783.77
  contributor:
    fullname: Long
– volume: 37
  start-page: S34
  year: 1992
  end-page: 7
  ident: CR48
  article-title: Adrenocorticotrophin and steroid-induced hypertension in humans
  publication-title: Kidney Int Suppl
  contributor:
    fullname: Whitworth
– volume: 17
  start-page: 35
  issue: 7
  year: 2016
  ident: CR83
  article-title: Assessment of brain tumor response: RANO and its offspring
  publication-title: Curr Treat Options Oncol
  doi: 10.1007/s11864-016-0413-5
  contributor:
    fullname: Lee
– volume: 3
  start-page: 17
  issue: 1
  year: 2001
  end-page: 21
  ident: CR38
  article-title: Mood and cognitive changes during systemic corticosteroid therapy
  publication-title: Prim Care Companion J Clin Psychiatry
  doi: 10.4088/PCC.v03n0104
  contributor:
    fullname: Chandler
– volume: 47
  start-page: 1087
  issue: 10
  year: 1984
  end-page: 90
  ident: CR19
  article-title: Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.47.10.1087
  contributor:
    fullname: Eadie
– volume: 21
  start-page: e493
  issue: 3
  year: 2014
  end-page: 503
  ident: CR31
  article-title: Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline
  publication-title: Curr Oncol
  doi: 10.3747/co.21.1769
  contributor:
    fullname: Easaw
– volume: 4
  start-page: 22
  issue: 1
  year: 2002
  end-page: 5
  ident: CR78
  article-title: A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas
  publication-title: Neuro-Oncology
  doi: 10.1215/15228517-4-1-22
  contributor:
    fullname: Carson
– volume: 25
  start-page: 699
  issue: 3
  year: 1996
  end-page: 717
  ident: CR52
  article-title: Growth suppression by glucocorticoid therapy
  publication-title: Endocrinol Metab Clin N Am
  doi: 10.1016/S0889-8529(05)70348-0
  contributor:
    fullname: Allen
– volume: 50
  start-page: 160
  issue: 2
  year: 2005
  end-page: 7
  ident: CR70
  article-title: Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells
  publication-title: Glia
  doi: 10.1002/glia.20168
  contributor:
    fullname: Banik
– volume: 15
  start-page: 1329
  issue: 12
  year: 2010
  end-page: 34
  ident: CR76
  article-title: Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0105
  contributor:
    fullname: Mikkelsen
– volume: 44
  start-page: 675
  issue: 4
  year: 1994
  end-page: 80
  ident: CR28
  article-title: Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day
  publication-title: Neurology
  doi: 10.1212/WNL.44.4.675
  contributor:
    fullname: van Putten
– volume: 246
  start-page: 568
  issue: 15
  year: 1952
  end-page: 71
  ident: CR1
  article-title: Cortisone and ACTH as an adjunct to the surgery of craniopharyngiomas
  publication-title: N Engl J Med
  doi: 10.1056/NEJM195204102461502
  contributor:
    fullname: Mc
– volume: 41
  start-page: 1235
  issue: 8
  year: 1991
  end-page: 9
  ident: CR41
  article-title: Steroid-induced weakness in patients with primary brain tumors
  publication-title: Neurology
  doi: 10.1212/WNL.41.8.1235
  contributor:
    fullname: Soong
– volume: 44
  start-page: 61
  issue: 1
  year: 2005
  end-page: 98
  ident: CR5
  article-title: Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-200544010-00003
  contributor:
    fullname: Haussler
– volume: 11
  start-page: 235
  issue: 3
  year: 1991
  end-page: 9
  ident: CR27
  article-title: Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases
  publication-title: J Neuro-Oncol
  doi: 10.1007/BF00165531
  contributor:
    fullname: Ritch
– volume: 27
  start-page: 69
  issue: 1
  year: 2000
  end-page: 83
  ident: CR4
  article-title: Symptom control in advanced cancer: important drugs and routes of administration
  publication-title: Semin Oncol
  contributor:
    fullname: Lipnickey
– volume: 15
  start-page: 993
  issue: 6
  year: 2000
  end-page: 1000
  ident: CR45
  article-title: Use of oral corticosteroids and risk of fractures
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.2000.15.6.993
  contributor:
    fullname: Cooper
– volume: 15
  start-page: 469
  issue: 5
  year: 2009
  end-page: 74
  ident: CR51
  article-title: Glucocorticoid-induced hyperglycemia
  publication-title: Endocr Pract
  doi: 10.4158/EP08331.RAR
  contributor:
    fullname: Thurby-Hay
– volume: 32
  start-page: 307
  issue: 3
  year: 1993
  end-page: 10
  ident: CR63
  article-title: Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy
  publication-title: Acta Oncol
  doi: 10.3109/02841869309093600
  contributor:
    fullname: Hirschberg
– volume: 81
  start-page: 46
  year: 1961
  end-page: 53
  ident: CR3
  article-title: Use of dexamethasone in treatment of cerebral edema associated with brain tumors
  publication-title: J Lancet
  contributor:
    fullname: Melby
– volume: 25
  start-page: 249
  issue: 4
  year: 2007
  end-page: 55
  ident: CR58
  article-title: Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide
  publication-title: Cancer Invest
  doi: 10.1080/07357900701206380
  contributor:
    fullname: Baden
– volume: 113
  start-page: 57
  issue: 1–2
  year: 1991
  end-page: 68
  ident: CR11
  article-title: The contribution of arachidonic acid to the aetiology and pathophysiology of focal brain oedema; studies using an infusion oedema model
  publication-title: Acta Neurochir
  doi: 10.1007/BF01402116
  contributor:
    fullname: Miller
– volume: 55
  start-page: 420
  issue: 3
  year: 2006
  end-page: 6
  ident: CR36
  article-title: Population-based assessment of adverse events associated with long-term glucocorticoid use
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21984
  contributor:
    fullname: George
– volume: 52
  start-page: 68
  issue: 1
  year: 2013
  end-page: 75
  ident: CR47
  article-title: Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kes353
  contributor:
    fullname: Rahman
– volume: 67
  start-page: 1799
  issue: 6
  year: 2010
  end-page: 815
  ident: CR6
  article-title: A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors
  publication-title: Neurosurgery
  doi: 10.1227/NEU.0b013e3181fa775b
  contributor:
    fullname: Hoggard
– volume: 31
  start-page: 1182
  issue: 9
  year: 2013
  end-page: 7
  ident: CR77
  article-title: Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.2012.43.9455
  contributor:
    fullname: Rodda
– ident: CR59
– volume: 60
  start-page: 4959
  issue: 17
  year: 2000
  end-page: 67
  ident: CR73
  article-title: Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis
  publication-title: Cancer Res
  contributor:
    fullname: Ellis
– volume: 8
  start-page: 1277
  issue: 7
  year: 1990
  end-page: 80
  ident: CR81
  article-title: Response criteria for phase II studies of supratentorial malignant glioma
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.1990.8.7.1277
  contributor:
    fullname: Cairncross
– volume: 17
  start-page: 880
  issue: 8
  year: 2014
  end-page: 6
  ident: CR30
  article-title: ACR Appropriateness Criteria(R) pre-irradiation evaluation and management of brain metastases
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2014.9417
  contributor:
    fullname: Germano
– volume: 163
  start-page: 1473
  issue: 16
  year: 1957
  end-page: 6
  ident: CR2
  article-title: Treatment of cerebral metastases from breast carcinoma with prednisolone
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1957.02970510039008
  contributor:
    fullname: Taylor
– volume: 281
  start-page: 32
  issue: 1
  year: 1969
  end-page: 4
  ident: CR18
  article-title: Interference in the effect of dexamethasone by diphenylhydantoin
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196907032810108
  contributor:
    fullname: Haque
– volume: 62
  start-page: 965
  issue: 4
  year: 2008
  ident: 713_CR24
  publication-title: Neurosurgery
  doi: 10.1227/01.neu.0000318183.25783.77
  contributor:
    fullname: S McClelland 3rd
– volume: 281
  start-page: 32
  issue: 1
  year: 1969
  ident: 713_CR18
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196907032810108
  contributor:
    fullname: EE Werk Jr
– volume: 27
  start-page: 69
  issue: 1
  year: 2000
  ident: 713_CR4
  publication-title: Semin Oncol
  contributor:
    fullname: D Walsh
– volume: 105
  start-page: 3339
  issue: 9
  year: 2008
  ident: 713_CR39
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0800165105
  contributor:
    fullname: L Sun
– volume: 16
  start-page: 1041
  issue: 9
  year: 2008
  ident: 713_CR53
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-007-0395-8
  contributor:
    fullname: A Sturdza
– volume: 90
  start-page: 638
  issue: 6
  year: 1999
  ident: 713_CR69
  publication-title: Jpn J Cancer Res
  doi: 10.1111/j.1349-7006.1999.tb00795.x
  contributor:
    fullname: T Kokunai
– volume: 83
  start-page: 682
  issue: 4
  year: 1995
  ident: 713_CR72
  publication-title: J Neurosurg
  doi: 10.3171/jns.1995.83.4.0682
  contributor:
    fullname: JG Strugar
– volume: 246
  start-page: 568
  issue: 15
  year: 1952
  ident: 713_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJM195204102461502
  contributor:
    fullname: FD Ingraham
– volume: 12
  start-page: 141
  issue: 4
  year: 1991
  ident: 713_CR16
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/0165-6147(91)90531-V
  contributor:
    fullname: BS McEwen
– volume: 47
  start-page: 1087
  issue: 10
  year: 1984
  ident: 713_CR19
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.47.10.1087
  contributor:
    fullname: JB Chalk
– volume: 966
  start-page: 73
  year: 2002
  ident: 713_CR42
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2002.tb04204.x
  contributor:
    fullname: E Canalis
– volume: 63
  start-page: 588
  issue: 5
  year: 2004
  ident: 713_CR50
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.010355
  contributor:
    fullname: S Mpofu
– volume: 15
  start-page: 469
  issue: 5
  year: 2009
  ident: 713_CR51
  publication-title: Endocr Pract
  doi: 10.4158/EP08331.RAR
  contributor:
    fullname: JN Clore
– ident: 713_CR67
  doi: 10.1007/978-94-011-0826-3_16
– volume: 32
  start-page: 307
  issue: 3
  year: 1993
  ident: 713_CR63
  publication-title: Acta Oncol
  doi: 10.3109/02841869309093600
  contributor:
    fullname: K Watne
– volume: 13
  start-page: 777
  issue: 10
  year: 2002
  ident: 713_CR44
  publication-title: Osteoporos Int
  doi: 10.1007/s001980200108
  contributor:
    fullname: TP Staa van
– volume: 40
  start-page: 1016
  issue: 5
  year: 1997
  ident: 713_CR71
  publication-title: Neurosurgery
  doi: 10.1097/00006123-199705000-00027
  contributor:
    fullname: J Provias
– volume: 48
  start-page: 406
  issue: 4
  year: 1991
  ident: 713_CR57
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1991.00530160074017
  contributor:
    fullname: JW Henson
– volume: 31
  start-page: 1182
  issue: 9
  year: 2013
  ident: 713_CR77
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.2012.43.9455
  contributor:
    fullname: L Recht
– volume: 51
  start-page: 65
  year: 1990
  ident: 713_CR10
  publication-title: Acta Neurochir Suppl (Wien)
  contributor:
    fullname: T Ohnishi
– volume: 25
  start-page: 249
  issue: 4
  year: 2007
  ident: 713_CR58
  publication-title: Cancer Invest
  doi: 10.1080/07357900701206380
  contributor:
    fullname: AB Schwarzberg
– volume: 15
  start-page: 1329
  issue: 12
  year: 2010
  ident: 713_CR76
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0105
  contributor:
    fullname: JJ Vredenburgh
– volume: 96
  start-page: 115
  issue: 2
  year: 1994
  ident: 713_CR32
  publication-title: Am J Med
  doi: 10.1016/0002-9343(94)90131-7
  contributor:
    fullname: KG Saag
– volume: 35
  start-page: 1610
  issue: 11
  year: 1985
  ident: 713_CR13
  publication-title: Neurology
  doi: 10.1212/WNL.35.11.1610
  contributor:
    fullname: KL Leenders
– volume: 96
  start-page: 103
  issue: 1
  year: 2010
  ident: 713_CR29
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-009-0057-4
  contributor:
    fullname: TC Ryken
– volume: 17
  start-page: 880
  issue: 8
  year: 2014
  ident: 713_CR30
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2014.9417
  contributor:
    fullname: SS Lo
– volume: 9
  issue: 11
  year: 2013
  ident: 713_CR66
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1003295
  contributor:
    fullname: H Kempf
– volume: 21
  start-page: e493
  issue: 3
  year: 2014
  ident: 713_CR31
  publication-title: Curr Oncol
  doi: 10.3747/co.21.1769
  contributor:
    fullname: X Kostaras
– volume: 50
  start-page: 160
  issue: 2
  year: 2005
  ident: 713_CR70
  publication-title: Glia
  doi: 10.1002/glia.20168
  contributor:
    fullname: P Sur
– volume: 37
  start-page: S34
  year: 1992
  ident: 713_CR48
  publication-title: Kidney Int Suppl
  contributor:
    fullname: JA Whitworth
– volume: 17
  start-page: 1114
  issue: 8
  year: 2015
  ident: 713_CR35
  publication-title: Neuro-Oncology
  doi: 10.1093/neuonc/nov054
  contributor:
    fullname: TS Armstrong
– volume: 28
  start-page: 51
  issue: 1
  year: 1989
  ident: 713_CR62
  publication-title: Acta Oncol
  doi: 10.3109/02841868909111181
  contributor:
    fullname: M Hohwieler Schloss
– volume: 34
  start-page: 1098
  issue: 8
  year: 2002
  ident: 713_CR56
  publication-title: Clin Infect Dis : Off Publ Infect Dis Soc Am
  doi: 10.1086/339548
  contributor:
    fullname: KA Sepkowitz
– volume: 4
  issue: 4
  year: 2014
  ident: 713_CR46
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-004259
  contributor:
    fullname: S Ajeganova
– ident: 713_CR59
– volume: 67
  start-page: 1799
  issue: 6
  year: 2010
  ident: 713_CR6
  publication-title: Neurosurgery
  doi: 10.1227/NEU.0b013e3181fa775b
  contributor:
    fullname: C Kotsarini
– volume: 24
  start-page: 229
  issue: 3
  year: 1990
  ident: 713_CR17
  publication-title: DICP
  doi: 10.1177/106002809002400301
  contributor:
    fullname: DM Cummings
– volume: 11
  start-page: 235
  issue: 3
  year: 1991
  ident: 713_CR27
  publication-title: J Neuro-Oncol
  doi: 10.1007/BF00165531
  contributor:
    fullname: DE Weissman
– volume: 16
  start-page: 23
  issue: 1
  year: 1981
  ident: 713_CR20
  publication-title: Surg Neurol
  doi: 10.1016/S0090-3019(81)80054-7
  contributor:
    fullname: LA Lawson
– volume: 90
  start-page: 207
  issue: 2
  year: 1979
  ident: 713_CR21
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-90-2-207
  contributor:
    fullname: JK Penry
– volume: 12
  start-page: 1886
  issue: 9
  year: 1994
  ident: 713_CR79
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.1994.12.9.1886
  contributor:
    fullname: CJ Watling
– volume: 44
  start-page: 61
  issue: 1
  year: 2005
  ident: 713_CR5
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-200544010-00003
  contributor:
    fullname: D Czock
– volume: 141
  start-page: 2945
  issue: 8
  year: 2000
  ident: 713_CR40
  publication-title: Endocrinology
  doi: 10.1210/endo.141.8.7621
  contributor:
    fullname: JR Singleton
– volume: 22
  issue: 5
  year: 2007
  ident: 713_CR25
  publication-title: Neurosurg Focus
  doi: 10.3171/foc.2007.22.5.13
  contributor:
    fullname: A Raslan
– volume: 169
  start-page: 491
  issue: 5
  year: 2012
  ident: 713_CR37
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11071009
  contributor:
    fullname: L Fardet
– volume: 44
  start-page: 675
  issue: 4
  year: 1994
  ident: 713_CR28
  publication-title: Neurology
  doi: 10.1212/WNL.44.4.675
  contributor:
    fullname: CJ Vecht
– volume: 157
  start-page: 142
  issue: 1
  year: 2007
  ident: 713_CR55
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2007.07950.x
  contributor:
    fullname: L Fardet
– volume: 573
  start-page: 413
  issue: Pt 2
  year: 2006
  ident: 713_CR7
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2006.106385
  contributor:
    fullname: C Forster
– volume: 139
  start-page: 1458
  issue: Pt 5
  year: 2016
  ident: 713_CR65
  publication-title: Brain :J Neurol
  doi: 10.1093/brain/aww046
  contributor:
    fullname: KL Pitter
– volume: 25
  start-page: 303
  issue: 3
  year: 2007
  ident: 713_CR80
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2006.09.002
  contributor:
    fullname: PA Armitage
– volume: 11
  start-page: 83
  issue: 1
  year: 2007
  ident: 713_CR74
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.11.021
  contributor:
    fullname: TT Batchelor
– volume: 81
  start-page: 46
  year: 1961
  ident: 713_CR3
  publication-title: J Lancet
  contributor:
    fullname: JH Galicich
– volume: 52
  start-page: 68
  issue: 1
  year: 2013
  ident: 713_CR47
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kes353
  contributor:
    fullname: JA Avina-Zubieta
– volume: 25
  start-page: 699
  issue: 3
  year: 1996
  ident: 713_CR52
  publication-title: Endocrinol Metab Clin N Am
  doi: 10.1016/S0889-8529(05)70348-0
  contributor:
    fullname: DB Allen
– volume: 81
  start-page: 505
  issue: 4
  year: 1974
  ident: 713_CR26
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-81-4-505
  contributor:
    fullname: JC Melby
– volume: 473
  start-page: 298
  issue: 7347
  year: 2011
  ident: 713_CR8
  publication-title: Nature
  doi: 10.1038/nature10144
  contributor:
    fullname: P Carmeliet
– volume: 4
  start-page: 233
  issue: 2
  year: 2011
  ident: 713_CR23
  publication-title: Expert Rev Clin Pharmacol
  doi: 10.1586/ecp.11.1
  contributor:
    fullname: J Dietrich
– volume: 28
  start-page: 1963
  issue: 11
  year: 2010
  ident: 713_CR82
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.2009.26.3541
  contributor:
    fullname: PY Wen
– volume: 583
  start-page: 322
  issue: 2–3
  year: 2008
  ident: 713_CR12
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2007.12.033
  contributor:
    fullname: R Malcher-Lopes
– volume: 100
  start-page: 89
  issue: 1
  year: 2010
  ident: 713_CR33
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-010-0142-8
  contributor:
    fullname: A Marantidou
– volume: 3
  start-page: 17
  issue: 1
  year: 2001
  ident: 713_CR38
  publication-title: Prim Care Companion J Clin Psychiatry
  doi: 10.4088/PCC.v03n0104
  contributor:
    fullname: ES Brown
– volume: 20
  start-page: 4757
  issue: 35
  year: 2001
  ident: 713_CR68
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204498
  contributor:
    fullname: T Glaser
– volume: 41
  start-page: 1235
  issue: 8
  year: 1991
  ident: 713_CR41
  publication-title: Neurology
  doi: 10.1212/WNL.41.8.1235
  contributor:
    fullname: EJ Dropcho
– volume: 18
  start-page: 1319
  issue: 10
  year: 2007
  ident: 713_CR43
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0394-0
  contributor:
    fullname: E Canalis
– volume: 17
  start-page: 35
  issue: 7
  year: 2016
  ident: 713_CR83
  publication-title: Curr Treat Options Oncol
  doi: 10.1007/s11864-016-0413-5
  contributor:
    fullname: SC Eisele
– volume: 70
  start-page: 407
  issue: 5–7
  year: 2005
  ident: 713_CR15
  publication-title: Steroids
  doi: 10.1016/j.steroids.2005.02.006
  contributor:
    fullname: J Zhou
– volume: 58
  start-page: 640
  issue: 4
  year: 2006
  ident: 713_CR14
  publication-title: Neurosurgery
  doi: 10.1227/01.NEU.0000204873.68395.A0
  contributor:
    fullname: ID Wilkinson
– volume: 10
  start-page: 322
  issue: 4
  year: 2002
  ident: 713_CR34
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-001-0333-0
  contributor:
    fullname: C Hempen
– volume: 163
  start-page: 1473
  issue: 16
  year: 1957
  ident: 713_CR2
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1957.02970510039008
  contributor:
    fullname: S Kofman
– volume: 113
  start-page: 57
  issue: 1–2
  year: 1991
  ident: 713_CR11
  publication-title: Acta Neurochir
  doi: 10.1007/BF01402116
  contributor:
    fullname: IR Whittle
– volume: 55
  start-page: 757
  issue: 5
  year: 1981
  ident: 713_CR9
  publication-title: J Neurosurg
  doi: 10.3171/jns.1981.55.5.0757
  contributor:
    fullname: ZY Yu
– volume: 8
  start-page: 1277
  issue: 7
  year: 1990
  ident: 713_CR81
  publication-title: J Clin Oncol : Off J Am Soc Clin Oncol
  doi: 10.1200/JCO.1990.8.7.1277
  contributor:
    fullname: DR Macdonald
– volume: 10
  year: 2014
  ident: 713_CR60
  publication-title: Cochrane Database System Rev
  doi: 10.1002/14651858.CD005590.pub3
  contributor:
    fullname: A Stern
– volume: 60
  start-page: 848
  issue: 5
  year: 1985
  ident: 713_CR22
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-60-5-848
  contributor:
    fullname: S Kawai
– volume: 55
  start-page: 420
  issue: 3
  year: 2006
  ident: 713_CR36
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21984
  contributor:
    fullname: JR Curtis
– volume: 10
  start-page: 222
  year: 2015
  ident: 713_CR64
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-015-0527-0
  contributor:
    fullname: LB Shields
– volume: 13
  start-page: 402
  year: 2013
  ident: 713_CR61
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-402
  contributor:
    fullname: SR Michaelsen
– volume: 66
  start-page: 1258
  issue: 8
  year: 2006
  ident: 713_CR75
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000208958.29600.87
  contributor:
    fullname: WB Pope
– volume: 15
  start-page: 993
  issue: 6
  year: 2000
  ident: 713_CR45
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.2000.15.6.993
  contributor:
    fullname: TP Staa Van
– volume: 309
  start-page: 21
  issue: 1
  year: 1983
  ident: 713_CR49
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198307073090105
  contributor:
    fullname: J Messer
– volume: 8
  issue: 11
  year: 2013
  ident: 713_CR54
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0078699
  contributor:
    fullname: K Migita
– volume: 60
  start-page: 4959
  issue: 17
  year: 2000
  ident: 713_CR73
  publication-title: Cancer Res
  contributor:
    fullname: S Yano
– volume: 4
  start-page: 22
  issue: 1
  year: 2002
  ident: 713_CR78
  publication-title: Neuro-Oncology
  doi: 10.1215/15228517-4-1-22
  contributor:
    fullname: J Portnow
SSID ssj0020079
Score 2.3267367
SecondaryResourceType review_article
Snippet Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and...
Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and treatment-related...
Background Corticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and...
BACKGROUNDCorticosteroids are commonly used in the management of primary central nervous system (CNS) tumors and CNS metastases to treat cancer- and...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 5
SubjectTerms Adrenal Cortex Hormones - adverse effects
Adrenal Cortex Hormones - therapeutic use
Animals
Brain Edema - etiology
Central Nervous System Neoplasms - complications
Central Nervous System Neoplasms - diagnostic imaging
Central Nervous System Neoplasms - drug therapy
Glioma - drug therapy
Humans
Magnetic Resonance Imaging
Medicine
Medicine & Public Health
Neoplasm Grading
Neuro-Oncology (LE Abrey
Neurology
Neurosciences
Section Editor
Topical Collection on Neuro-Oncology
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFH_MDcSL3x_VKRU8KRlN0rTpcch0KFNQB_NUmjaDMWnFdQf9603SjynTw855pO17L-8z71eAC4ppEjOPI88NJNKdJhQkBKM4iF29EDBziWbw4PWH7t2IjRpA6tJFOu1UHUljqBezbiqz0HeodGUNU-StQaucO211b1_ve3WapagDg5Kq60ZKJ6te5l-b_PZGSyHmUnvUeJ2brWIScGbACvVlk2lnnotO_LUM5bjCB23DZhmE2t1Ca3agIdNdWB-UbfY9oCVa6Jv9pMfPtWLY2dh-VjLIJok9nEl7ktoG1wM9pgb3-nMfhje9l-s-Kv-ugGLqkxwJwiNXZR-OjFSWh0UUEalOt4qBIuoJR0rJKfcSx_eVA_OZ8KhOFWMVz7hjGiljcADNNEvlEdiC-EEgGE4SEbncoSKRbkzGwuEi0TmJBZcVl8P3AkQjXMAlazaEig2hZkOoiNuVHMLyPM1CzD1GGA8YseC8XlYnQbc3olRmc0NDiYarcyw4LORXP41wTJU5xRZcVcL4sfl_r3K8EvUJbBAjTV2faUMz_5jLUxWx5OKsVNFvxPDb8A
  priority: 102
  providerName: Springer Nature
Title Clinical Relevance of Steroid Use in Neuro-Oncology
URI https://link.springer.com/article/10.1007/s11910-017-0713-6
https://www.ncbi.nlm.nih.gov/pubmed/28138871
https://www.proquest.com/docview/1865258952
https://search.proquest.com/docview/1863219140
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD64DUSfvFudo4JPSrBNekmfZMrmUDZFHcyn0jQZDEY73fbgv_ckazdl6GsT0vDlcs53vuQE4IK5TKZ-wEngRYpopYlEkrokjVJPF0S-OUTT7QWdvvcw8AdFwG1aHKss90SzUcs81THya5cHPvV55NObyQfRr0ZpdbV4QqMCNYpMwalC7bbVe35ZUi60gJHJmKpjSDg_S13TXJ5DqqIPZelQnctI8Nsyrbmba1KpsUDtHdjWtxLsRSh_FzZUtgeb3UIY3wdW5PccY42xMrK-nQ_tV0QtH0m7P1X2KLNNJg7ylJlM1V8H0G-33u46pHgPgaQspDMiKE885AuOSpCXuSJJqML1iF5LwgLhKKU444F0whBNTuiLgGlyl6IH4g1Zgsv3EKpZnqljsAUNo0j4rpQi8bjDhFReSofC4UJqFmHBZYlFPFmkvYhXCY41cDECF2vgYqxcL9GKixUwjVfjZcH5shjnrhYkkkzlc1OHUZ1gzrHgaIHy8m-Uuww3QNeCqxL2H43_1ZWT_7tyClvUDLgOodShOvucqzN0KmaiAZVwEDag1rx_f2w1inmEX_u0-Q2d4sbO
link.rule.ids 314,315,783,787,795,12068,21400,27934,27936,27937,31731,31732,33756,33757,41093,41535,42162,42604,43322,43817,52123,52246,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB1BkVhO7JQ1SJxAFomdxTlxQFQF2nKglXqL4tiVKlVJoe2Bv2fGTVpQBWdbifM88ax-A3AjPKGzIJQs9GPDKNPEYs09lsWZTwNxYIto2p2w2fNf-kG_DLhNyrLK6ky0B7UuMoqR33syDHgg44A_jD8YdY2i7GrZQmMdNoiHizoYRP2lw4X6L7Z8qRRBQumsspr26hw6KlSSRYE6T7Dwt15aMTZXEqVW_zR2YYfuJDjzQP4erJl8HzbbZVr8AETJ7jnCGSNjk_pOMXDeEbNiqJ3exDjD3LE8HOwttzzVX4fQazx1H5us7IbAMhHxKVNcpj56C65J0SvzVJpyg5-MNksqQuUaY6SQoXajCBVOFKhQkGuXof3hD0SKP-8R1PIiNyfgKB7FsQo8rVXqS1cobfyMD5QrlSYfog63FRbJeE56kSzpjQm4BIFLCLgEJ59XaCWl_E-S5W7V4XoxjJJL6Yg0N8XMzhGc6OXcOhzPUV68jUtP4PHn1eGugv3Hw_9ayun_S7mCrWa33Upaz53XM9jmdvMpmHIOtennzFygeTFVl1aGvgEou8T1
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7oBkOfvDudWsEnJdgmbZo-CV6G1znUgW-laVIYjFbdfPDfe5KlUxF9zqENX05yrvkCcMACpvKIC8LDRBNTaSKJogHJkzw0A0lkm2juevxyEF4_R8-u_2ns2irrM9Ee1KrKTY78OBA8opFIInpcuLaI_nn35OWVmBekTKXVPacxD8045MxvQPP0otd_mIVfaA0Ty55q8kmoq3WN016kw7DFNGiZtF3ACP9ppX65nr_KptYadZdg0dxQ8KZp_WWY0-UKtO5ckXwVmOP6HKHESNsSv1cV3iMiWA2VNxhrb1h6lpWD3JeWtfpjDQbdi6ezS-LeRiA5i-mESCqyEGMHX2cYowUyy6jGvYkeTMa49LXWggmu_DhG8xNHkjMT6OXojYQFy3Arr0OjrEq9CZ6kcZLIKFBKZqHwmVQ6zGkhfSGViSjacFhjkb5MKTDSL7JjA1yKwKUGuBSFOzVaqdsN4_Rr7dqwPxtGPTbFiazU1buVYdSQzflt2JiiPPsbFQHDwzBow1EN-7eP_zWVrf-nsgctVKD09qp3sw0L1K69yax0oDF5e9c76GtM5K5Tok8rj8qS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Relevance+of+Steroid+Use+in+Neuro-Oncology&rft.jtitle=Current+Neurology+and+Neuroscience+Reports&rft.au=Ly%2C+K+Ina&rft.au=Wen%2C+Patrick+Y&rft.date=2017-01-01&rft.pub=Springer+Nature+B.V&rft.issn=1528-4042&rft.eissn=1534-6293&rft.volume=17&rft.issue=1&rft.spage=1&rft_id=info:doi/10.1007%2Fs11910-017-0713-6&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4312395391
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-4042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-4042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-4042&client=summon